Nurix Therapeutics, Inc. · NASDAQ:NRIX

van Houte Hans sold 2,388 Nurix Therapeutics, Inc. shares (Form 4)

Traded Apr 30, 2026 · Filed Apr 30, 2026

On Apr 30, 2026, van Houte Hans (Chief Financial Officer) sold 2,388 Nurix Therapeutics, Inc. shares at US$16.65 for US$39,760, leaving 51,647 shares. Filed Apr 30, 2026 (Form 4).

Sold
2,388 shares
Price
US$16.65
Value
US$39,760
Holding after
51,647 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 30, 2026Common StockOption exercise2,00047,427Direct
Apr 30, 2026Common StockOption exercise3,75051,177Direct
Apr 30, 2026Common StockOption exercise2,85854,035Direct
Apr 30, 2026Common StockSale2,388US$16.6551,647Direct

Source

View original at SEC

Related